SecProbe.io

CORRESP
1
filename1.htm

    Sheppard,
    Mullin, Richter & Hampton LLP

    30
    Rockefeller Plaza

    New
    York, New York 10112-0015

    212.653.8700
    main

    212.653.8701
    fax

    www.sheppardmullin.com

December
22, 2023

    U.S.
    Securities and Exchange Commission

    Division
    of Corporate Finance

    100
    F Street, NE

    Washington,
    D.C. 20549

    Attn:

    Robert
    Shapiro

    Theresa
    Brillant

    Scott
    Anderegg

    Mara
    Ransom

    Re:
    Alta
    Global Group Ltd

    Registration
    Statement on Form F-1

    Filed
    November 17, 2023

    File
    No. 333-275618

Ladies
and Gentlemen:

This
letter sets forth the responses of Alta Global Group Ltd, an Australian public company limited by shares (the “Company”),
to the comments received from the Staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”)
on December 5, 2023 concerning the Company’s Registration Statement on Form F-1 filed with the Commission on November 17, 2023
(the “Registration Statement”).

References
in the text of the responses herein to captions and page numbers refer to Amendment No. 1 to the Company’s Registration Statement
on Form F-1 (the “Amended Registration Statement”), which is being filed herewith.

Registration
Statement on Form F-1, Filed November 17, 2023

Company
Overview, page 1

    1.
    We
    note your response to our comment 1. Please augment your disclosure to quantify the number of participants or subscribers, current
    and historical on a comparative basis, for at least the last 2 fiscal years.

Response:

The
Company acknowledges the Staff’s comment and has expanded its disclosure in the Amended Registration Statement on pages 1 and 42
to include program and participant numbers for fiscal years 2021 through 2023.

Management’s
Discussion and Analysis of Financial Condition and Results of Operations

Liquidity
and Capital Resources, page 38

    2.
    Please
    reconcile for us the $6,346,000 raised from convertible notes for the period from June 2023 to October 2023 with the $8,655,252 in
    proceeds from convertible notes in your statement of cash flows for the year ended June 30, 2023 and revise your disclosure accordingly.

Response:

The
Company acknowledges the Staff’s comment and informs the Staff that the $6,346,009 raised from convertible notes relates to the
Private Placement convertible note issuance on June 9, 2023 which was the final issuance of convertible notes by Company. Please refer
to the Company’s response in comment 4 below for a reconciliation to the $8,655,252 in proceeds from convertible notes, net of
transaction costs, as disclosed in the Consolidated Statement of Cash Flows, to the face value of convertible notes issued during the
year ended June 30, 2023.

In
response to the Staff’s comment, the Company has revised its disclosure in the Amended Registration Statement on page 38.

Government
Regulations, page 59

    3.
    We
    note your revised disclosure in response to comment 11. Please augment your disclosure to disclose how all the various regulations
    have impacted or affected your business, where material.

Response:

The
Company acknowledges the Staff’s comment and has expanded its disclosure in the Amended Registration Statement in the risk factors
on page 20, and under the heading “Government Regulations” on page 60.

Alta
Global Group Limited Financial Statements for the Years Ended June 30, 2023 and 2022 Consolidated Statements of Cash Flows for the Years
Ended June 30, 2023 and 2022, page F-6

    4.
    Please
    reconcile for us the proceeds of $8,655,252 received from the private placement of convertible notes for the year ended June 30,
    2023 with the disclosure of the issuance of convertible promissory notes during fiscal year 2023 as disclosed in Note 21.

Response:

The
Company acknowledges the Staff’s comment and has prepared the below reconciliation of the proceeds of $8,655,252 received from
the issuance of convertible notes during the year ended June 30, 2023, as disclosed in the Consolidated Statement of Cash Flows, with
the disclosure of the issuance of convertible promissory notes during fiscal year 2023 as disclosed in Note 21.

Please
note, that the $8,655,252 amount does not only include the proceeds received from the private placement, but also includes the proceeds
received from the Series B2, Series A Extension and the Reach convertible note issuances.

Please
refer to the table below for the requested reconciliation.

    Reconciliation of proceeds from convertible notes with the issuance of convertible notes during fiscal year 2023
    AUD$

    Series B2 face value (1)
      671,284

    Series A Extension face value (1)
      1,571,873

    Reach face value (1)
      3,195,000

    Private Placement face value (1)
      9,215,591

    Total face value issued in fiscal year 2023
      14,653,748

    Less: Reach rollover to Private Placement (2)
    $ (3,025,841 )

    Less: Proceeds received after June 30, 2023 (3)
    $ (1,932,860 )

    Less: Notes issued In lieu of payment for services (4)
    $ (624,425 )

    Less: Other costs (5)
    $ (415,370 )

    Proceed received from the private placement of convertible notes (6)
    $ 8,655,252

(1)
Refer to Note 21 of the Consolidated Financial Statements for key terms of the convertible notes and the amount raised per series, which
includes issue Date, conversion date, term (years), face value, interest rate and conversion discount (Qualified Equity Investment).
Please note that a disclosure describing Qualified Equity Investment has been added on page F-30 (please refer to comment 8 below).

(2)
Refer to Note 21 of the Consolidated Financial Statements on page F-31 which states that $3,025,841 of Reach convertible notes, inclusive
of accrued interest, were rolled into the Private Placement on June 9, 2023.

(3)
Refer to Note 10 of the Consolidated Financial Statements on page F- 23 for updated disclosure which identifies proceeds from convertible
notes that had not yet been received by the Company at June 30, 2023 (please refer to comment 7 below).

(4)
Refer to convertible notes issued in lieu of payment for services in Note 18 of the Consolidated Financial Statements on page F-26.

(5)
Other costs include capital raising expenses pertaining to convertible notes which are netted off against the carrying value of the convertible
note liability upon initial measurement and amortized over the life of the note.

(6)
Refer to Cash flows from financing activities in the Consolidated Statement of Cash Flows on page F-6.

Notes
to Consolidated Financial Statements

Note
2: Significant accounting policies

Revenue
Recognition, page F-9

    5.
    We
    note that you enter into license agreements with your partner gyms to run your training program within their gyms. We also note that
    the licensing fee is determined by the number of participants in each series and is paid by your partner gyms in the form of a revenue
    share agreement. This appears to be a sales-based royalty arrangement pursuant to IFRS 15. Please tell us how you determined that
    it is appropriate to recognize the full amount of the US training fees, instead of only the portion of the fee you are entitled to
    under the contract. Please provide a comprehensive analysis supporting your current treatment.

Response:

The
below analysis should be read in conjunction with Note 2 – Significant accounting policies, Revenue Recognition on page F-9.

Management
has performed the following analysis with regard to the recognition of the full amount of revenue from license agreements by applying
principles in IFRS 15 paragraphs B52 to B63B.

License
arrangements

B52
states, “A licence establishes a customer’s rights to the intellectual property of an entity.”

Applying
B52 above, the Company’s license transfers its intellectual property (“IP”) to the partner gyms pursuant to the terms
of a license agreement which states, “We grant to you a non sub-licensable, non-assignable, non-transferable license to use the
System.”

The
“System” is defined in the license agreement as “our plan, design (or future rebranded design), method and system for
the development and operation of the ALTA Warrior Program, culminating in a finale, and including our IP.”

B53-54
states that an “entity shall account for the promise to grant a licence and those other promised goods or services together
as a single performance obligation.”

Applying
B53-54 above, the Company’s single performance obligation under the license agreement is completed via the provision of the Company’s
IP and the roll out of the training program.

B58
states, “The nature of an entity’s promise in granting a licence is a promise to provide a right to access the entity’s
intellectual property if all” criteria are met.

Applying
B58 above, the Company does not undertake activities that significantly affect the IP granted under the license agreement and the IP
transferred under the license agreement to the partner gyms remains unchanged. Therefore, the Company does not satisfy the criteria of
B58.

B61
states that “the nature of an entity’s promise is to provide a right to use the entity’s intellectual property as
that intellectual property exists (in terms of form and functionality) at the point in time at which the licence is granted to the customer.”

Accordingly,
B61 is applicable when the Company does not meet the criteria of B58.

The
partner gyms have the right to use the IP as it exists (in terms of form and functionality) at the point in time the license is granted.
It is at this point that control is effectively passed to the customer and the Company has fulfilled its promise and thereby can recognize
the revenue at that point in time.

Usage
based royalty

B63
states that “an entity shall recognise revenue for a sales-based or usage-based royalty promised in exchange for a licence of
intellectual property only when (or as) the later of the following events occurs:

    (a)
    The
    subsequent sale or usage occurs; and

    (b)
    The
    performance obligation to which some or all of the sales based royalty has been allocated has been satisfied (or partially satisfied).”

Applying
B63, the license agreements between the Company and the partner gyms, are a usage-based royalty arrangement, and as such the Company
recognizes the full amount of revenue for the training program when the later of the below criteria are met:

    (a)
    the
    usage occurs - on commencement of the training program; and

    (b)
    the
    Company’s performance obligation under these license agreement is met via the provision of the System (Company IP) as agreed
    in the license agreement on signing of the licence agreement.

Consequently
applying (a) and (b) above, the associated revenue is recognized in full upon usage at the commencement of the training program. It is
at this point that control is passed to the partner gym and is the point in time at which the Company recognizes the revenue.

Principal
and agent analysis

B37
states, “Indicators that an entity controls the specified good or service before it is transferred to the customer (and is
therefore a principal) (see paragraph B35) include, but are not limited to, the following:

(a)
the entity is primarily responsible for fulfilling
the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good
or service (for example, primary responsibility for the good or service meeting customer specifications). If the entity is primarily
responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing
the specified good or service is acting on the entity’s behalf.

(b)
the entity has inventory risk before the specified good or service has been transferred to a customer or after transfer of control to
the customer (for example, if the customer has a right of return). For example, if the entity obtains, or commits itself to obtain, the
specified good or service before obtaining a contract with a customer, that may indicate that the entity has the ability to direct the
use of, and obtain substantially all of the remaining benefits from, the good or service before it is transferred to the customer.

(c)
the entity has discretion in establishing the price for the specified good or service. Establishing the price that the customer pays
for the specified good or service may indicate that the entity has the ability to direct the use of that good or service and obtain substantially
all of the remaining benefits. However, an agent can have discretion in establishing prices in some cases. For example, an agent may
have some flexibility in setting prices in order to generate additional revenue from its service of arranging for goods or services to
be provided by other parties to customers.

Further
supporting the above, by applying B37, the Company has primary control of a good or service before it is transferred to partner gyms
because:

    (a)
    The
    Company has primary responsibility for ensuring the good or service meets customer specifications as agreed in the license agreement
    noted above, including maintaining the Company’s IP.

    (b)
    Neither
    the Company nor the partner gyms holds inventory in respect of the Company’s IP, therefore this element of the IFRS 15.B37
    guidance is not applicable.

    (c)
    The
    training program price charged to a participant is determined by the Company and is set out in a typical license agreement with the
    partner gyms.

Based
on the application IFRS 15 paragraphs B63 and B37, as detailed above, the Company controls the good or service before transferring to
the customer and sets and determines the price of its products for its customers.

Therefore,
management has determined that the Company is a principal for purposes of IFRS 15.B34-B38 and discloses revenues as revenue from program
fees less the contractual obligations payable to gyms, deriving net revenue from program fees as disclosed in the Consolidated Financial
Statements.

The
contractual obligations payable to gyms are agreed in the license agreement between the Company and the gym and as noted above, are calculated
on a percentage basis of program fees. Therefore as the Company is required to remit this obligation to the customer, it is represented
on the face of the profit and loss and throughout the Consolidated Financial Statements as a component of net revenue from program fees.

This
approach is used in all geographies where the Company operates, not only US training fees.

Other
Income, page F-10

    6.
    Please
    disclose whether the refundable research and development grant program is available in future periods, and if so, the expected term
    of your participation. See paragraph 39 of IAS20.

Response:

The
Company acknowledges the Staff’s comment and has included the requested disclosure in the Amended Registration Statement on page
F-19.

Note
10. Trade and other receivables, page F-23

    7.
    Please
    disclose the amounts due from the issuance of Convertible Notes included in Other advances at June 30, 2023 and tell us when these
    receivables were collected subsequent to year end.

Response:

The
Company acknowledges the Staff’s comment and has included the requested disclosure in the Amended Registration Statement on page
F-23.

The
Company advises the Staff that an amount of AUD $1,932,860 (other advances) was collected between July and August 2023. Please refer
to the table in comment 4.

Note
21. Financial Liabilities, page F-29

    8.
    Please
    disclose what is meant by the “Qualified Equity Investment” feature for the conversion discount for the convertible notes.

Response:

The
Company acknowledges the Staff’s comment and